← Open Payments lookup

AMY BIANCONE: Open Payments

NPI 1568452100 · CUMBERLAND, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$818 in 44 payments from 14 companies in 2025. Trend: 2023 $733 · 2024 $616 · 2025 $818

Food & beverage: $818
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP10$179
Novo Nordisk Inc8$171
ABBVIE INC.10$169
Astellas Pharma US Inc3$54
Boehringer Ingelheim Pharmaceuticals, Inc.3$53
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$40
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$22
Phathom Pharmaceuticals, Inc.1$22
Boston Scientific Corporation1$20
Abbott Laboratories1$20

Products named: UBRELVY, AIRSUPRA, Ozempic, VRAYLAR, BREZTRI, Rybelsus, Veozah, JARDIANCE.

Industry payments across MD — which companies pay providers there.